1. Home
  2. BWAY vs OVID Comparison

BWAY vs OVID Comparison

Compare BWAY & OVID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

N/A

Current Price

$10.25

Market Cap

468.5M

Sector

Health Care

ML Signal

N/A

OVID

Ovid Therapeutics Inc.

N/A

Current Price

$2.56

Market Cap

503.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BWAY
OVID
Founded
2003
2014
Country
Israel
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
468.5M
503.9M
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
BWAY
OVID
Price
$10.25
$2.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
13
Target Price
★ $19.27
$6.40
AVG Volume (30 Days)
101.5K
★ 2.4M
Earning Date
11-10-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 3.90
EPS
★ N/A
N/A
Revenue
N/A
★ $7,252,000.00
Revenue This Year
$33.61
N/A
Revenue Next Year
$23.01
N/A
P/E Ratio
$81.98
★ N/A
Revenue Growth
N/A
★ 1181.27
52 Week Low
$10.21
$1.18
52 Week High
$26.63
$3.11

Technical Indicators

Market Signals
Indicator
BWAY
OVID
Relative Strength Index (RSI) 38.54 50.37
Support Level N/A $2.12
Resistance Level $12.12 $2.67
Average True Range (ATR) 0.59 0.24
MACD -0.00 0.03
Stochastic Oscillator 3.43 44.95

Price Performance

Historical Comparison
BWAY
OVID

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

Share on Social Networks: